Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

  1. OncologyPRO
  2. Meeting resources
  3. ESMO Asia 2017 Congress

ESMO Colloquium - Selection criteria for the treatment of castration-resistant prostate cancer (crpc)

Conclusion

Date

18 Nov 2017

Session

ESMO Colloquium - Selection criteria for the treatment of castration-resistant prostate cancer (crpc)

Presenters

Marniza Saad

Authors

M. Saad

Author affiliations

  • Kuala Lupur/MY
More

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Introduction

Presenter: Marniza Saad

Session: ESMO Colloquium - Selection criteria for the treatment of castration-resistant prostate cancer (crpc)

Resources:

Slides

Webcast

Outcome with Cytotoxic agents

Presenter: Vesa Kataja

Session: ESMO Colloquium - Selection criteria for the treatment of castration-resistant prostate cancer (crpc)

Resources:

Slides

Webcast

Criteria for treatment choice decision

Presenter: Vesa Kataja

Session: ESMO Colloquium - Selection criteria for the treatment of castration-resistant prostate cancer (crpc)

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.